FDA Drug recall D-0570-2024
Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 3877…
- FDA Drug
- Class II
- completed
- Published 2024-07-10
On 2024-07-10 the FDA classified a Class II recall of Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 3877… by Medisca, citing CGMP Deviations and Presence of Particulate Matter: Glass.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0570-2024 |
| Classification | Class II |
| Status | completed |
| Initiated | 2024-06-26 |
| Published | 2024-07-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Medisca |
| Distribution | US |
Product
Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.
Reason
CGMP Deviations and Presence of Particulate Matter: Glass
Identifiers
| code_info | Lot #s: 202323/G, 202323/H, Exp. 07/31/2026 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0570-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.